‘Old fashioned’ doctors in new GP contract
November 15, 2013Sales and Marketing BMA, GP, Hunt, Labour, NHS, UK, doctors
The government is changing GPs’ contract with the NHS in a bid to “bring back old-fashioned family doctors” who will …
Pharma slams PPRS deal
November 15, 2013Medical Communications, Sales and Marketing ABPI, PPRS, VBP, telegraph
The fallout from last week’s new drug pricing plan in the UK is continuing as nine pharma firms write an …
Questcor adds Elan president to its Board
November 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Elan, Questcor, martin
Biopharma firm Questcor Pharmaceuticals has appointed Elan’s president and chief executive G. Kelly Martin to its Board of directors. Martin has …
Roche signs $17 million immatics deal
November 15, 2013Research and Development, Sales and Marketing Cancer, Roche, immatics, lung, prostate
Roche is to pay German biotech company immatics $17 million to collaborate on the search for vaccines in various cancers, …
J&J ‘to pay out $4 billion’ in fresh legal case
November 14, 2013Sales and Marketing J&J, JJ, Risperdal, fines, hip replacement
Johnson & Johnson is set to pay up to $4 billion to settle thousands of legal cases related to patients …
Philippines typhoon: pharma response
November 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philippines typhoon, pharma
Staff from pharma companies on the ground in the Philippines appear to have escaped the worst following the typhoon which …
Janssen/Pharmacyclics gain FDA nod for Imbruvica
November 14, 2013Sales and Marketing FDA, Janssen, Pharmacyclics, Revlimid, Velcade
The FDA has approved Janssen and Pharmacyclics’ Imbruvica to treat patients with mantle cell lymphoma (MCL), a rare and aggressive …
EMA delays data transparency
November 14, 2013Medical Communications, Research and Development, Sales and Marketing EMA, FDA, all trials, transparency
The European Medicines Agency has delayed its much-trailed plan to launch a clear policy on making clinical trial data publically …
ISPE names vice president of Europe
November 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ISPE
The International Society for Pharmaceutical Engineering which is the world’s largest not-for-profit association, has appointed former Boehringer head Dr Thomas …
Dendreon slashes more jobs
November 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Dendreon, Provenge, cuts
Another 150 jobs are to go at Dendreon Corporation as the company seeks to cut $125 million per year in …
GSK heart disease drug fails late-stage trial
November 13, 2013Sales and Marketing GSK, darapladib, heart, statin
GSK has said its investigational chronic coronary heart disease pill darapladib has failed to meet its primary endpoint in a …
New Policy manager for the ABPI
November 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, andrew
The ABPI has appointed Andrew Hollingsworth as its new Policy manager who will take up the position on 25 November. …
SMC approves Inlyta
November 13, 2013Sales and Marketing Pfizer, SMC, Sutent, inylta, rcc
Pfizer’s kidney cancer drug Inlyta has been approved by the drugs watchdog in Scotland, making it the only country in …
NHS Confederation hires new chief executive and deputy chair
November 12, 2013Sales and Marketing Mike Farrar, NHS, NHS Confederation, Rob webster, cash
The NHS Confederation has confirmed that Rob Webster is to succeed Mike Farrar as its new chief executive, as it …
Amgen commits $2.5 million to biotech educational grants
November 12, 2013Research and Development, Sales and Marketing Amgen, EDC, Onyx, biotech, stem
The Amgen Foundation has announced $2.5 million in new grants for its science programme to aid schools in the US …
Eisai signs tropical disease deal
November 12, 2013Research and Development, Sales and Marketing Disease, Eisai, Japan, broad, ntd, tropical
Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …
Novartis takes top honours in ISPE facility competition
November 12, 2013Manufacturing and Production Novartis, WHO, foya, holly springs
Novartis’ cell culture facility in the US for the production of influenza vaccines has claimed the top prize in the …
NICE needs more Velcade data
November 12, 2013Sales and Marketing NHS, NICE, Velcade, eric low
NICE has slowed the progress of Janssen Cilag’s Velcade towards becoming an NHS treatment for multiple myeloma by asking the …
Celgene hires new medical director
November 12, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, kilcoyne
Biopharma firm Celgene has announced the appointment of Dr Adrian Kilcoyne as its new medical director. He will take up …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
